KMPA in severe feud

Published: 2012-04-13 06:58:00

Updated: 2012-04-13 06:58:00

The leadership of the Korea Pharmaceutical Manufacturers Association (KPMA) is facing a backlash as Korea’s leading pharmaceutical firms, the association’s former executive members, are still refusing to join in the new line-up.

Several large drug makers, including Dong-A Pharma and Yuhan Corp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK